etafilcon A control lens (1DM)
DeviceA marketed daily disposable contact lens
Other names: 1-DAY ACUVUE MOIST Brand Contact Lenses
NCT Number: NCT01484028
This study will serve to evaluate and compare the performance of two new lenses to a marketed lens.
Looking for future studies?
Notify Me18 year–34 year
Female
Interventional
Not applicable
Advanced Optometry, Mission Viejo, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A marketed daily disposable contact lens
Other names: 1-DAY ACUVUE MOIST Brand Contact Lenses
A daily disposable contact lens
A daily disposable contact lens
Time frame: Dispensing
Monocular distance Snellen visual acuity (VA) scores were coverted to the algorithm of the minimal angle of resolution (LogMAR) scale based on the following formula: LogMAR = Log10 (VA/20) - a*VAR, where Log10 = base 10 logarithm, VA = the Snellen denominator score, a = LogMAR stepsize coefficient and VAR = letter gained or missing in addition to the Snellen denominator score.
Time frame: Dispensing
The overall lens fit was evaluated by the Investigators for each eye whether it was acceptable (yes/no).
Time frame: After 7-9 days of lens wear
Corneal staining was graded using a 5-point scale; 0=None(no staining), 1=Trace, 2=Mild, 3=Moderate, and 4=Severe. Only those eyes with corneal staining grade >= 3 were reported.
Johnson & Johnson Vision Care, Inc.
Industry
Clinical Validation of Etafilcon A With Print and PVP Contact Lenses for Dark Eyes and Light Eyes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05565937
Refractive Ametropia
San Diego, California, United States
View Trial DetailsNCT05766787
Eye Diseases, Myopia
Los Angeles, California, United States
View Trial DetailsNCT05765227
Eye Diseases, Presbyopia
Johns Creek, Georgia, United States
View Trial DetailsNCT06053736
Refractive Ametropia
Rochester, New York, United States
View Trial Details